Phenylketonuria, Maternal
Rare Disease·MeSH: Phenylketonuria, Maternal
Prevalence
6.0 / 100K
Incidence
1.2 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 4(1)
| Drug | Company |
|---|---|
| pegvaliase | BIOMARIN PHARMACEUTICAL INC (BMRN) |
Frequently asked questions
How many drugs are in development for Phenylketonuria, Maternal?
BioSniper tracks 1 drug in development for Phenylketonuria, Maternal across 1 company.
How many clinical trials target Phenylketonuria, Maternal?
There are 1 clinical trial targeting Phenylketonuria, Maternal tracked by BioSniper.
What is the prevalence of Phenylketonuria, Maternal?
The estimated prevalence of Phenylketonuria, Maternal is approximately 6.0 per 100,000 population.
Deep-dive into Phenylketonuria, Maternal
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis